{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,8]],"date-time":"2026-10-08T08:50:33Z","timestamp":1791449433639,"version":"4.3.3"},"reference-count":24,"publisher":"Springer Science and Business Media LLC","issue":"10","license":[{"start":{"date-parts":[[2026,8,6]],"date-time":"2026-08-06T00:00:00Z","timestamp":1785974400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"},{"start":{"date-parts":[[2026,8,6]],"date-time":"2026-08-06T00:00:00Z","timestamp":1785974400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"}],"funder":[{"DOI":"10.13039\/501100013671","name":"Sun Pharma","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100013671","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Dermatol Ther (Heidelb)"],"published-print":{"date-parts":[[2026,10]]},"DOI":"10.1007\/s13555-026-01841-8","type":"journal-article","created":{"date-parts":[[2026,8,6]],"date-time":"2026-08-06T18:22:42Z","timestamp":1786040562000},"page":"4931-4944","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Effectiveness and Tolerability of Low-Dose Micronized Isotretinoin in Patients with Severe Recalcitrant Nodular Facial Acne in India: a Real-World Retrospective Study Using Electronic Medical Records"],"prefix":"10.1007","volume":"16","author":[{"given":"Byalakere S.","family":"Chandrashekar","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maya","family":"Vedamurthy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Seetharamanjaneyulu","family":"Kolalapudi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vijaya Bhaskar","family":"Mallela","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shahnaz","family":"Arsiwala","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anil","family":"Ganjoo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abir","family":"Saraswat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Farida","family":"Modi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sowmya C.","family":"Sujatha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Satish","family":"Udare","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Surajit","family":"Gorai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mukesh","family":"Gabhane","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bhavesh","family":"Lalan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gaurang","family":"Jani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aditi","family":"Jain","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shruti","family":"Dharmadhikari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chintan","family":"Khandhedia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Prashant","family":"Devkare","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amey","family":"Mane","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Asif","family":"Shaikh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Suyog","family":"Mehta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,8,6]]},"reference":[{"key":"1841_CR1","doi-asserted-by":"publisher","DOI":"10.1016\/J.BBREP.2023.101578","volume":"36","author":"M Vasam","year":"2023","unstructured":"Vasam M, Korutla S, Bohara RA. Acne vulgaris: a review of the pathophysiology, treatment, and recent nanotechnology based advances. Biochem Biophys Rep. 2023;36:101578. https:\/\/doi.org\/10.1016\/J.BBREP.2023.101578.","journal-title":"Biochem Biophys Rep"},{"issue":"9813","key":"1841_CR2","doi-asserted-by":"publisher","first-page":"361","DOI":"10.1016\/S0140-6736(11)60321-8","volume":"379","author":"HC Williams","year":"2012","unstructured":"Williams HC, Dellavalle RP, Garner S. Acne vulgaris. Lancet. 2012;379(9813):361\u201372. https:\/\/doi.org\/10.1016\/S0140-6736(11)60321-8.","journal-title":"Lancet"},{"issue":"2","key":"1841_CR3","doi-asserted-by":"publisher","first-page":"228","DOI":"10.1093\/BJD\/LJAE352","volume":"192","author":"Z Zhu","year":"2025","unstructured":"Zhu Z, Zhong X, Luo Z, Liu M, Zhang H, Zheng H, et al. Global, regional and national burdens of acne vulgaris in adolescents and young adults aged 10\u201324\u2005years from 1990 to 2021: a trend analysis. Br J Dermatol. 2025;192(2):228\u201337. https:\/\/doi.org\/10.1093\/BJD\/LJAE352.","journal-title":"Br J Dermatol"},{"issue":"5","key":"1841_CR4","doi-asserted-by":"publisher","first-page":"1016","DOI":"10.1016\/j.jaad.2023.12.038","volume":"90","author":"JH Saurat","year":"2024","unstructured":"Saurat JH, Halioua B, Baissac C, Cullell NP, Ben Hayoun Y, Aroman MS, et al. Epidemiology of acne and rosacea: a worldwide global study. J Am Acad Dermatol. 2024;90(5):1016\u20138. https:\/\/doi.org\/10.1016\/j.jaad.2023.12.038.","journal-title":"J Am Acad Dermatol"},{"issue":"11","key":"1841_CR5","doi-asserted-by":"publisher","first-page":"3672","DOI":"10.1111\/jocd.14040","volume":"20","author":"N Shah","year":"2021","unstructured":"Shah N, Shukla R, Chaudhari P, Patil S, Patil A, Nadkarni N, et al. Prevalence of acne vulgaris and its clinico\u2010epidemiological pattern in adult patients: Results of a prospective, observational study. J Cosmet Dermatol. 2021;20(11):3672\u20138. https:\/\/doi.org\/10.1111\/jocd.14040.","journal-title":"J Cosmet Dermatol"},{"key":"1841_CR6","doi-asserted-by":"publisher","first-page":"1","DOI":"10.7573\/DIC.2021-8-6","volume":"10","author":"AKC Leung","year":"2021","unstructured":"Leung AKC, Barankin B, Lam JM, Leong KF, Hon KL. Dermatology: how to manage acne vulgaris. Drugs Context. 2021;10:1. https:\/\/doi.org\/10.7573\/DIC.2021-8-6.","journal-title":"Drugs Context"},{"key":"1841_CR7","volume-title":"Isotretinoin. Handbook of Systemic Drug Treatment in Dermatology","author":"HD Pile","year":"2025","unstructured":"Pile HD, Patel P, Sadiq NM. Isotretinoin. Handbook of Systemic Drug Treatment in Dermatology. 2nd ed. CRC Press; 2025. (PubMed PMID: 30247824).","edition":"2"},{"issue":"3","key":"1841_CR8","doi-asserted-by":"publisher","first-page":"162","DOI":"10.4161\/DERM.1.3.9364","volume":"1","author":"A Layton","year":"2009","unstructured":"Layton A. The use of isotretinoin in acne. Dermatoendocrinol. 2009;1(3):162. https:\/\/doi.org\/10.4161\/DERM.1.3.9364.","journal-title":"Dermatoendocrinol"},{"issue":"4","key":"1841_CR9","doi-asserted-by":"publisher","first-page":"451","DOI":"10.1111\/IJD.15089;SUBPAGE:STRING:ABSTRACT;WEBSITE:WEBSITE:PERICLES;WGROUP:STRING:PUBLICATION","volume":"60","author":"H Fallah","year":"2021","unstructured":"Fallah H, Rademaker M. Isotretinoin in the management of acne vulgaris: practical prescribing. Int J Dermatol. 2021;60(4):451\u201360. https:\/\/doi.org\/10.1111\/IJD.15089;SUBPAGE:STRING:ABSTRACT;WEBSITE:WEBSITE:PERICLES;WGROUP:STRING:PUBLICATION. (PubMed PMID: 32860434).","journal-title":"Int J Dermatol"},{"issue":"3","key":"1841_CR10","doi-asserted-by":"publisher","first-page":"432","DOI":"10.1002\/JVC2.154","volume":"2","author":"AU Daly","year":"2023","unstructured":"Daly AU, Baptista Gon\u00e7alves R, Lau E, Bowers J, Hussaini N, Charalambides M, et al. A systematic review of isotretinoin dosing in acne vulgaris. JEADV Clin Pract. 2023;2(3):432\u201349. https:\/\/doi.org\/10.1002\/JVC2.154.","journal-title":"JEADV Clin Pract"},{"issue":"12 Suppl 1","key":"1841_CR11","first-page":"S18","volume":"14","author":"R Bellomo","year":"2021","unstructured":"Bellomo R, Brunner M, Tadjally E. New formulations of isotretinoin for acne treatment: expanded options and clinical implications. J Clin Aesthet Dermatol. 2021;14(12 Suppl 1):S18 (PubMed PMID: 35291260).","journal-title":"J Clin Aesthet Dermatol"},{"issue":"4","key":"1841_CR12","doi-asserted-by":"publisher","first-page":"644","DOI":"10.1016\/j.jaad.2005.11.1061","volume":"54","author":"B Amichai","year":"2006","unstructured":"Amichai B, Shemer A, Grunwald MH. Low-dose isotretinoin in the treatment of acne vulgaris. J Am Acad Dermatol. 2006;54(4):644\u20136. https:\/\/doi.org\/10.1016\/j.jaad.2005.11.1061. (PubMed PMID: 16546586).","journal-title":"J Am Acad Dermatol"},{"issue":"1","key":"1841_CR13","doi-asserted-by":"publisher","DOI":"10.1111\/DTH.14438","volume":"34","author":"A Sadeghzadeh-Bazargan","year":"2021","unstructured":"Sadeghzadeh-Bazargan A, Ghassemi M, Goodarzi A, Roohaninasab M, Najar Nobari N, Behrangi E. Systematic review of low-dose isotretinoin for treatment of acne vulgaris: Focus on indication, dosage, regimen, efficacy, safety, satisfaction, and follow up, based on clinical studies. Dermatol Ther. 2021;34(1):e14438. https:\/\/doi.org\/10.1111\/DTH.14438. (PubMed PMID: 33085149).","journal-title":"Dermatol Ther"},{"issue":"6","key":"1841_CR14","first-page":"665","volume":"13","author":"GF Webster","year":"2014","unstructured":"Webster GF, Leyden JJ, Gross JA. Results of a Phase III, double-blind, randomized, parallel-group, non-inferiority study evaluating the safety and efficacy of isotretinoin-Lidose in patients with severe recalcitrant nodular acne. J Drugs Dermatol. 2014;13(6):665\u201370 (PubMed PMID: 24918555).","journal-title":"J Drugs Dermatol"},{"issue":"9","key":"1841_CR15","first-page":"15","volume":"13","author":"AL Zaenglein","year":"2020","unstructured":"Zaenglein AL, Segal J, Darby C, Del RJQ. Lidose-isotretinoin administered without food improves quality of life in patients with severe recalcitrant nodular acne: an open-label, single-arm, phase IV Study. J Clin Aesthet Dermatol. 2020;13(9):15 (PubMed PMID: 33133336).","journal-title":"J Clin Aesthet Dermatol"},{"issue":"11","key":"1841_CR16","first-page":"13","volume":"12","author":"JQ Del Rosso","year":"2019","unstructured":"Del Rosso JQ, Gold LS, Segal J, Zaenglein AL. An Open-label, Phase IV Study evaluating Lidose-isotretinoin administered without food in patients with severe recalcitrant nodular acne: low relapse rates observed over the 104-week post-treatment period. J Clin Aesthet Dermatol. 2019;12(11):13 (PubMed PMID: 32038751).","journal-title":"J Clin Aesthet Dermatol"},{"issue":"2","key":"1841_CR17","doi-asserted-by":"publisher","first-page":"196","DOI":"10.1067\/mjd.2001.115966","volume":"45","author":"JS Strauss","year":"2001","unstructured":"Strauss JS, Leyden JJ, Lucky AW, Lookingbill DP, Drake LA, Hanifin JM, et al. Safety of a new micronized formulation of isotretinoin in patients with severe recalcitrant nodular acne: A randomized trial comparing micronized isotretinoin with standard isotretinoin. J Am Acad Dermatol. 2001;45(2):196\u2013207. https:\/\/doi.org\/10.1067\/mjd.2001.115966. (PubMed PMID: 11464180).","journal-title":"J Am Acad Dermatol"},{"issue":"2","key":"1841_CR18","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1067\/MJD.2001.115965","volume":"45","author":"JS Strauss","year":"2001","unstructured":"Strauss JS, Leyden JJ, Lucky AW, Lookingbill DP, Drake LA, Hanifin JM, et al. A randomized trial of the efficacy of a new micronized formulation versus a standard formulation of isotretinoin in patients with severe recalcitrant nodular acne. J Am Acad Dermatol. 2001;45(2):187\u201395. https:\/\/doi.org\/10.1067\/MJD.2001.115965.","journal-title":"J Am Acad Dermatol"},{"issue":"5","key":"1841_CR19","doi-asserted-by":"publisher","first-page":"378","DOI":"10.4103\/2229-5178.190505","volume":"7","author":"D Dhaked","year":"2016","unstructured":"Dhaked D, Meena R, Maheshwari A, Agarwal U, Purohit S. A randomized comparative trial of two low-dose oral isotretinoin regimens in moderate to severe acne vulgaris. Indian Dermatol Online J. 2016;7(5):378. https:\/\/doi.org\/10.4103\/2229-5178.190505. (PubMed PMID: 27730033).","journal-title":"Indian Dermatol Online J"},{"issue":"5","key":"1841_CR20","doi-asserted-by":"publisher","first-page":"296","DOI":"10.4103\/1947-489X.210559","volume":"5","author":"NA El-Sherif","year":"2013","unstructured":"El-Sherif NA, Greiw AS, Benamer AM. Efficacy of daily low dose versus intermittent isotretinoin regimens in patients with moderate acne vulgaris: a randomized-controlled trial. Ibnosina J Med BS. 2013;5(5):296\u2013302. https:\/\/doi.org\/10.4103\/1947-489X.210559.","journal-title":"Ibnosina J Med BS"},{"issue":"4","key":"1841_CR21","doi-asserted-by":"publisher","first-page":"233","DOI":"10.4103\/JRPP.JRPP_17_30","volume":"6","author":"G Faghihi","year":"2017","unstructured":"Faghihi G, Mokhtari F, Fard N, Motamedi N, Hosseini S. Comparing the efficacy of low dose and conventional dose of oral isotretinoin in treatment of moderate and severe acne vulgaris. J Res Pharm Pract. 2017;6(4):233. https:\/\/doi.org\/10.4103\/JRPP.JRPP_17_30. (PubMed PMID: 29417084).","journal-title":"J Res Pharm Pract"},{"issue":"6","key":"1841_CR22","doi-asserted-by":"publisher","first-page":"1369","DOI":"10.1111\/J.1365-2133.2010.10152.X","volume":"164","author":"JW Lee","year":"2011","unstructured":"Lee JW, Yoo KH, Park KY, Han TY, Li K, Seo SJ, et al. Effectiveness of conventional, low-dose and intermittent oral isotretinoin in the treatment of acne: a randomized, controlled comparative study. Br J Dermatol. 2011;164(6):1369\u201375. https:\/\/doi.org\/10.1111\/J.1365-2133.2010.10152.X. (PubMed PMID: 21114478).","journal-title":"Br J Dermatol"},{"issue":"6","key":"1841_CR23","doi-asserted-by":"publisher","first-page":"423","DOI":"10.36849\/JDD.7863","volume":"23","author":"JQ Del Rosso","year":"2024","unstructured":"Del Rosso JQ, Kircik L. Efficacy and safety of micronized isotretinoin administered once daily without food in patients with recalcitrant nodular acne. J Drugs Dermatol. 2024;23(6):423\u20138. https:\/\/doi.org\/10.36849\/JDD.7863. (PubMed PMID: 38834211).","journal-title":"J Drugs Dermatol"},{"issue":"5","key":"1841_CR24","doi-asserted-by":"publisher","first-page":"945","DOI":"10.1016\/J.JAAD.2015.12.037","volume":"74","author":"AL Zaenglein","year":"2016","unstructured":"Zaenglein AL, Pathy AL, Schlosser BJ, Alikhan A, Baldwin HE, Berson DS, et al. Guidelines of care for the management of acne vulgaris. J Am Acad Dermatol. 2016;74(5):945-973.e33. https:\/\/doi.org\/10.1016\/J.JAAD.2015.12.037. (PubMed PMID: 26897386).","journal-title":"J Am Acad Dermatol"}],"updated-by":[{"DOI":"10.1007\/s13555-026-01904-w","type":"correction","label":"Correction","source":"publisher","updated":{"date-parts":[[2026,9,5]],"date-time":"2026-09-05T00:00:00Z","timestamp":1788566400000}}],"container-title":["Dermatology and Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s13555-026-01841-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s13555-026-01841-8","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s13555-026-01841-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,8]],"date-time":"2026-10-08T08:00:22Z","timestamp":1791446422000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s13555-026-01841-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8,6]]},"references-count":24,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2026,10]]}},"alternative-id":["1841"],"URL":"https:\/\/doi.org\/10.1007\/s13555-026-01841-8","relation":{},"ISSN":["2193-8210","2190-9172"],"issn-type":[{"value":"2193-8210","type":"print"},{"value":"2190-9172","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,8,6]]},"assertion":[{"value":"21 April 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 June 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 August 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 September 2026","order":5,"name":"change_date","label":"Change Date","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Correction","order":6,"name":"change_type","label":"Change Type","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"A Correction to this paper has been published:","order":7,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"https:\/\/doi.org\/10.1007\/s13555-026-01904-w","URL":"https:\/\/doi.org\/10.1007\/s13555-026-01904-w","order":8,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors Bhavesh Lalan, Gaurang Jani, Aditi Jain, Shruti Dharmadhikari, Chintan Khandhedia, Prashant Devkare, Amey Mane, Asif Shaikh and Suyog Mehta are full-time employees of Sun Pharma, Mumbai, India, who funded the study. Mukesh Gabhane was a full-time employee of the organization during the conduct of this study. These authors had no role in data retrieval and analysis. The authors Byalakere S. Chandrashekar, Maya Vedamurthy, Seetharamanjaneyulu Kolalapudi, Vijaya Bhaskar Mallela, Shehnaz Arsiwala, Anil Ganjoo, Abir Saraswat, Farida Modi, Soumya C. Sujatha, Satish Udare, and Surajit Gorai have nothing to disclose.","order":1,"name":"Ethics","label":"Conflict of Interest","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study was approved by the Royal Pune Independent Ethics Committee (RPIEC), located in Pune, India (ethics committee registration no. ECR\/45\/Indt\/MH\/2013\/RR-19, ethics approval no. RPIEC210824; dated August 20, 2024). This study used aggregated and anonymized data retrieved from electronic medical records. No additional prospective components (assessments, follow-ups, etc.) were included in the study. Therefore, before starting data collection for this study, the EC granted a waiver for informed consent in accordance with the ICMR- National Ethical Guidelines for Biomedical and Health Research Involving Human Participants, 2017.","order":2,"name":"Ethics","label":"Ethical Approval","group":{"name":"EthicsHeading","label":"Declarations"}}]}}